The Biognosys Grant Program is a periodic initiative designed to support clinical-stage research in a selected disease area by applying our innovative large-scale proteomics techniques. The program was created to support Biognosys’ mission of making the proteome accessible to life science researchers by inventing new cutting-edge technologies that provide deep, multi-dimensional insights on protein expression, function, and structure at large scale.
Biognosys awards the winner research group with a complete large-scale proteomic analysis, expert consultation, project management, and in-depth data analysis.
We want to thank all the talented participants from all over the world who applied to the Grant Programs: we appreciated all submitted projects’ uniqueness and high quality.
This year’s edition with Parker Institute for Cancer Immunotherapy is focused on metastatic pancreatic cancer.
To always be updated on our news and not lose the possibility to participate in future editions of the Biognosys Grant Program:
Access our knowledge base with relevant resources and guiding information.